Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]

第三条 内幕信息知情人在内幕信息公开前负有保密义务。内幕 信息知情人应在获悉内幕信息的同时，告知董事会秘书室，由董事会 秘书室填写《内幕信息知情人登记表》，并备案。 第四条 在内幕信息依法公开披露前，公司应当填写内幕信息知 情人档案，及时记录商议筹划、论证咨询、合同订立等阶段及报告、 传递、编制、决议、披露等环节的内幕信息知情人名单，及其知悉内 幕信息的时间、地点、依据、方式、内容等信息。 工股份有限公司内幕信息知情人和外部信息使用人管理制度》等法律 法规和规章，特制定本管理制度。 第二条 董事会应当保证内幕信息知情人档案真实、准确和完整， 董事长为主要责任人。董事会秘书负责内幕信息知情人的登记入档事 宜。 第五条 内幕信息知情人登记备案的内容，包括但不限于内幕信 息知情人的姓名、职务、身份证号、证券账户、工作单位、知悉的内 幕信息、知悉的途径及方式、知悉的时间、保密条款。 上海氯碱化工股份有限公司 内幕信息知情人登记管理制度 第一条 为完善公司内幕信息管理制度，做好内幕信息保密工作， 有效防范和打击内幕交易等证券违法违规行为，根据《证券法》《上 市公司监管指引第 5 号——上市公司内幕信息知情人登记管理制度 ...

Group 1 - The core point of the article is that Chlor-Alkali Chemical announced a steam supply contract with Guotou Qinzhou Second Power Co., Ltd., involving a total steam procurement of approximately 1.44 million tons per year for a duration of 20 years [1] - The contract will be executed in two phases, with the first phase involving a procurement of 180 tons per hour and the second phase 240 tons per hour, ensuring a supply duration of no less than 8,000 hours per year [1] - For the first half of 2025, the revenue composition of Chlor-Alkali Chemical is reported as follows: industrial segment accounts for 91.21%, trading segment for 8.18%, and other businesses for 0.61% [1] Group 2 - As of the latest report, the market capitalization of Chlor-Alkali Chemical is 13.6 billion yuan [2]

Core Viewpoint - Chlor-alkali Chemical (600618.SH) has announced the signing of a steam supply contract with Guotou Qinzhou Second Power Generation Co., Ltd., which will significantly enhance its operational capabilities and secure long-term steam supply for its subsidiary [1] Group 1: Contract Details - The contract involves a total steam procurement volume of approximately 336,000 tons per year, divided into two phases: 144,000 tons/year for the first phase and 192,000 tons/year for the second phase [1] - The contract duration is set for 20 years, from April 2026 to March 2046, ensuring a stable supply of steam for the company [1] - The steam supply contract specifies a delivery rate of 180-240 tons/hour, with a minimum supply duration of 8,000 hours per year [1]

Group 1 - The core viewpoint of the article is that Chlor-Alkali Chemical (600618.SH) plans to invest in an advanced materials supporting waste salt comprehensive utilization project in the Qinzhou Port Economic and Technological Development Zone, with a total investment of 2.975 billion yuan [1] - The project will include the construction of production facilities for 300,000 tons/year of caustic soda, 250,000 tons/year of vinyl chloride, and 300,000 tons/year of polyvinyl chloride [1] - The project aligns with the industrial development plan of the Huayi Qinzhou Chemical New Materials Integrated Base, utilizing waste salt as a raw material for caustic soda production, promoting resource recycling and enhancing the overall competitiveness and green development capabilities of the base [1] Group 2 - To fund the project, the company plans to increase its capital contribution to Guangxi Chlor-Alkali Company by 893 million yuan [1] - The project aims to provide key raw materials for downstream facilities such as epoxy resin and epichlorohydrin, thereby achieving a circular economy in the chlorine resource industry chain [1] - The initiative is expected to promote regional industrial collaboration and resource optimization [1]

Core Viewpoint - Chlor-alkali Chemical (600618.SH) announced a capital increase of 893 million yuan for its wholly-owned subsidiary, Guangxi Huayi Chlor-alkali Chemical Co., Ltd., to invest in the "Advanced Materials Supporting Waste Salt Comprehensive Utilization Project," with a total project investment of 2.975 billion yuan [1] Group 1: Project Details - The project includes the construction of production facilities for 300,000 tons/year of caustic soda, 250,000 tons/year of vinyl chloride, and 300,000 tons/year of polyvinyl chloride [1] - The company will inject capital in phases according to the project progress, while the remaining funds will be raised by Guangxi Chlor-alkali Company itself [1] Group 2: Compliance and Market Outlook - The project aligns with national industrial policies, and the main products have a reliable market [1] - The technology used in the project is advanced, and it is expected to have significant environmental benefits [1] Group 3: Risks - There are risks associated with the source of raw material waste salt, project construction, and product sales [1]

上海氯碱化工股份有限公司 投资者关系管理实施细则 第一章 总则 第一条 为保护投资者的合法权益，切实做好投资者关系管理工 作，本着公平、诚信、勤勉的原则，特制定本细则。 第二章 管理机构 第二条 董事会秘书室负责公司投资者关系管理事务，董事长为 投资者关系管理第一责任人，董事会秘书为投资者关系管理实施人。 第三条 投资者关系管理工作职责： 1、拟定投资者关系管理制度，建立工作机制； 2、组织与投资者沟通联络的投资者关系管理活动； 3、组织及时妥善处理投资者咨询、投诉和建议等诉求，定期反馈 给公司董事会以及管理层； 4、管理、运行和维护投资者关系管理的相关渠道和平台； 5、保障投资者依法行使股东权利； 6、配合支持投资者保护机构开展维护投资者合法权益的相关工 作； 7、统计分析公司投资者的数量、构成以及变动等情况； 8、开展有利于改善投资者关系的其他活动。 第四条 投资者关系管理工作人员应积极参加中国证监会、上海 证券交易所举办的专业培训和公司内部的学习、培训，掌握公司投资 1 者关系管理的内容及程序，全面了解公司发展规划、发展战略、经营 状况等各种信息。 第五条 对公司与投资者关系出现或可能出现危机时提出有效 ...

上海氯碱化工股份有限公司 内部审计管理制度 第一章 总则 第一条 为了充分发挥上海氯碱化工股份有限公司（以下简称 "公司"）内部审计职能，明确内部审计部门的职责与权限，维护公 司资产的安全与完整，协助提升公司运营效率与公司价值，根据《审 计署关于内部审计工作的规定》及中国证监会有关规定，结合公司实 际，制订本制度。 第二条 本制度所称内部审计，是指公司审计部门依据有关法律 法规和公司内部管理规定，对公司内部及所属单位的经济活动、内部 控制的适当性、合法性及有效性进行审计监督和实施工程项目的审核 管理，并提出改善经营管理的意见和建议。 第三条 本制度适用于公司及内部独立核算单位、控股子公司、 公司投资虽未控股但有实际控制权的企业。 第四条 本制度规定了公司内部审计机构和审计人员、内部审计 机构的职责和权限、内部审计工作程序等规范，为公司内部审计管理 指南。 第二章 内部审计机构和内部审计人员 第五条 审计部是公司内部审计的归口管理部门，依据有关规定 开展内部审计工作，对董事会负责，向董事会审计委员会（以下简称 审计委员会）报告工作。内部审计机构在监督检查过程中，应当接受 审计委员会的监督指导。内部审计机构发现公 ...

上海氯碱化工股份有限公司 内幕信息知情人登记管理制度 第一条 为完善公司内幕信息管理制度，做好内幕信息保密工作， 有效防范和打击内幕交易等证券违法违规行为，根据《证券法》《上 市公司监管指引第 5 号——上市公司内幕信息知情人登记管理制度》 《上海氯碱化工股份有限公司信息披露事务管理制度》《上海氯碱化 工股份有限公司内幕信息知情人和外部信息使用人管理制度》等法律 法规和规章，特制定本管理制度。 第二条 董事会应当保证内幕信息知情人档案真实、准确和完整， 董事长为主要责任人。董事会秘书负责内幕信息知情人的登记入档事 宜。 第三条 内幕信息知情人在内幕信息公开前负有保密义务。内幕 信息知情人应在获悉内幕信息的同时，告知董事会秘书室，由董事会 秘书室填写《内幕信息知情人登记表》，并备案。 第四条 在内幕信息依法公开披露前，公司应当填写内幕信息知 情人档案，及时记录商议筹划、论证咨询、合同订立等阶段及报告、 传递、编制、决议、披露等环节的内幕信息知情人名单，及其知悉内 幕信息的时间、地点、依据、方式、内容等信息。 第五条 内幕信息知情人登记备案的内容，包括但不限于内幕信 息知情人的姓名、职务、身份证号、证券账户、工作 ...

上海氯碱化工股份有限公司 信息披露事务管理制度 第一章 总则 第一条 为规范信息披露，维护公司形象和股东权益，根据《上市公 司信息披露管理办法》和公司章程等规定，制定本制度。 第二条 本制度所指信息披露是指公司在中国证监会指定的报刊和网 站上披露的定期报告和临时报告。 第三条 公司信息披露义务人为公司董事、高级管理人员和各部门、 各控股子公司的主要负责人、公司的关联人。信息披露义务人应当真实、 准确、完整、及时地披露信息，不得有虚假记载、误导性陈述或者重大遗 漏。信息披露义务人应当同时向所有投资者公开披露信息，在境内、外市 场披露的信息需同步并一致。 信息披露义务人暂缓、豁免披露信息的，应当遵守法律、行政法规和 中国证监会的规定。 第四条 公司的董事、高级管理人员应当忠实、勤勉地履行职责，保 证披露信息的真实、准确、完整、及时、公平。 第一节 定期报告 第五条 公司应当披露的定期报告包括年度报告、中期报告和季度报 告。凡是对投资者做出投资决策有重大影响的信息，均应当披露。 年度报告中的财务会计报告应当经具有证券、期货相关业务资格的会 1 计师事务所审计。 第六条 年度报告应当在每个会计年度结束之日起 4 个月 ...